- Stefano is Okairos co-founder, molecular biologist – responsible for the development of the technology based on viral vectors (chimpanzee adenoviruses, MVA).
- He worked in MRL, the research division of Merck & Co., from 1990 to 2007 being initially involved in different drug discovery projects in the field of antivirals against HBV and HCV.
- In 1997 he worked in Canada as visiting scientist at McMaster University on gutless adenoviral vector system for gene therapy applications.
- Since 2000 he focused on the development of a platform technology based on chimpanzee adenoviral vector for genetic vaccine applications by establishing new adenoviral vector systems that were validated in human clinical trials.
18 Apr 2017 - News